THE FIGHT INHERITED RETINAL BLINDNESS! PROJECT: A NEW TREATMENT OUTCOME AND NATURAL HISTORY REGISTRY FOR INHERITED RETINAL DISEASE

Macular Diseases

Outcomes After Switching to Faricimab in Neovascular Age-Related Macular Degeneration: Data From the Fight Retinal Blindness! Registry

Clin Exp Ophthalmol

Hunt A, Hashimoto Y, Young S, Arnold J, Game J, Hooper C, Field A, Barry R, Barthelmes D, Gillies M

doi: 10.1111/ceo.14589

Retinal Diseases

The value of age of onset and family history as predictors of molecular diagnosis in a Swedish cohort of inherited retinal disease

Acta Ophthalmol

De Geer K, Löfgren S, Lindstrand A, Kvarnung M, Björck E

doi: 10.1111/aos.16804

Retinal Diseases

Racial Disparities in Genetic Detection Rates for Inherited Retinal Diseases

JAMA Ophthalmol

Abuzaitoun RO, Branham KH, Lacy GD, Hufnagel RB, Kumar MM, Koskenvuo JW, Tuupanen S, Durham T, Zhao PY, Abalem MF, Andrews CA, Schlegel D, Khan NW, Fahim AT, Heckenlively JR, Musch DC, Jayasundera KT

doi: 10.1001/jamaophthalmol.2024.4696

Retinal Diseases

Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment Outcomes: IRIS® Registry (Intelligent Research in Sight) Analysis

Ophthalmol Retina

Griffin S, Chan L, McCarthy K, Peng X, Li C, Harrison LD, Lum F, Shah G

doi: 10.1016/j.oret.2024.10.025

Macular DiseasesRetinal Diseases

Impact of AI-quantified fluid dynamics on visual outcomes over 5 years in patients with treatment-naïve nAMD from the FRB! registry

Sci Rep

Fuchs P, Schmidt-Erfurth U, Coulibaly LM, Bogunovic H, Leingang O, Gruber A, Frommlet F, Mares V, Barthelmes D, Reiter GS

doi: 10.1038/s41598-025-17417-z

Retinal Diseases

Inherited retinal disease pathway in the UK: a patient perspective and the potential of AI

Br J Ophthalmol

Wong W, Sumodhee D, Morris T, Tailor B, Hollyhead C, Woof WA, Archer S, Veal C, Lobo L, Al-Khuzaei S, Varela MD, C de Guimaraes TA, Gomes M, Shah M, Moosajee M, Downes SM, Madhusudhan S, Mahroo OA, Webster AR, Michaelides M, Pontikos N

doi: 10.1136/bjo-2024-327074

Retinal Diseases

Treatment Patterns and Long-Term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database

Ophthalmol Retina

Ip M, Modi Y, Fekrat S, Gibson K, Boucher N, Arrisi P, Ishii F, Liu Y, Paris LP, Fenech M, Chi GC

doi: 10.1016/j.oret.2025.05.025

Retinal Diseases

Characterisation and prevalence of inherited retinal diseases in the Finnish population reveals enrichment of population-specific phenotypes and causative variants

Br J Ophthalmol

Lähteenoja L, Ohtonen P, Falck A, Rahikkala EJ

doi: 10.1136/bjo-2025-327427

Macular Diseases

Long-Term Natural History of Treatment-Naïve Geographic Atrophy in Age-Related Macular Degeneration

Transl Vis Sci Technol

Muth DR, Quérat L, Venkataraman AP, Dominguez-Vicent A, Petrovski G, Williams PA, Locri F, Zweifel SA, Kvanta A

doi: 10.1167/tvst.14.5.5

Related content

Outcomes After Switching to Faricimab in Neovascular Age-Related Macular Degeneration: Data From the Fight Retinal Blindness! Registry

The value of age of onset and family history as predictors of molecular diagnosis in a Swedish cohort of inherited retinal disease

Racial Disparities in Genetic Detection Rates for Inherited Retinal Diseases

Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment Outcomes: IRIS® Registry (Intelligent Research in Sight) Analysis

Impact of AI-quantified fluid dynamics on visual outcomes over 5 years in patients with treatment-naïve nAMD from the FRB! registry

Inherited retinal disease pathway in the UK: a patient perspective and the potential of AI

Treatment Patterns and Long-Term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database

Characterisation and prevalence of inherited retinal diseases in the Finnish population reveals enrichment of population-specific phenotypes and causative variants

Long-Term Natural History of Treatment-Naïve Geographic Atrophy in Age-Related Macular Degeneration